Zopiclone Withdrawal and Tapering Help
Sleeping Pills are one of the fastest growing categories in consumer health worldwide, leaving many at risk of dependence. Our NonProfit has been helping people withdraw safely for over 15 Years.
the Prescription Drug Experts for help.
Real Results for Zopiclone Dependency
The Point of Return Program is an in-home tapering program that allows you to gradually lessen the amount of Zopiclone while also implementing the use of all-natural, calming nutraceuticals to help ease symptoms. We
eliminate Interaction items to help make Zopiclone withdrawal more comfortable. Our physician recommended schedules allow your doctor to taper you off Zopiclone correctly. The success of our program is due to our unmatched service and unique mentoring approach. Zopiclone can be dangerous to abruptly or rapidly stop and our program is a proven, viable, low-cost option to continue living
your life while tapering.
Read program FAQ page.
We are experts that specialize in Sleeping Pill withdrawals.
Key Components of Our In-Home Program
- Skilled Experts guiding you throughout the process
Assessment at the onset to determine a gameplan
*Nutraceuticals specially formulated to help ease symptoms, these are utilized throughout the whole process
- Unlike herbs and many vitamins, our nutraceuticals will not interact with any medications
- 24/7 discussion board with encouraging members and knowledgeable mentors
Recommendations for addressing symptoms
- Experienced team of committed experts with 15 years experience
Break Free Today
At Point of Return, a 501(c)3 nonprofit, we have spent the last 15 years helping people come off Zopiclone correctly. With customized taper rates and all natural nutraceuticals, our program allows you to taper off Zopiclone, once and for all, from the comfort of your home.
Read program FAQs
reach out for help
Zopiclone history and info
Zopiclone is a nonbenzodiazepine hypnotic agent used in the treatment of insomnia and is recommended for short-term use only (7 consecutive days). Z drugs were initially thought to be less addictive but time has shown a high risk of dependence and withdrawal symptoms. Initially Zopiclone was marketed as a safer alternative to benzodiazepines but a meta analysis (quantitative statistical analysis) found there are few clear and consistent differences between Zopiclone and benzodiazepines in terms of sleep onset, sleep duration, number of awakenings, quality of sleep, adverse events, tolerance, rebound insomnia and daytime alertness. More common reactions to Zopiclone show a reduction in total time spent in REM sleep.
Zopiclone has shown it may have a greater addictive potential than Benzodiazepines and has been described as a "benzodiazepine in disguise". Tolerance to the effects of Zopiclone can develop after a few weeks and abrupt withdrawal (particularly after prolonged use) can cause seizures and delirium. Due to the high dependence risk and effect on the GABA receptor, a gradual taper is recommended.
Zopiclone can cause horrible withdrawal symptoms that include a worsening of sleep and anxiety. It is critical to stop this drug properly and that is why our nonprofit was formed nearly 12 years ago. We know the importance of a slow-taper to allow the GABA receptors time to readjust at each reduction, but more importantly is getting the GABA receptors back to a healthy state so true sleep returns. Our program addresses each component of Zopiclone withdrawal - correct taper rates; all-natural items to ease symptoms; removing any interaction items through vitamins, over-the-counter, herbs, etc that actually increase symptoms and augmenting true healing.
It was introduced on the world market in 1988 but is not available in the United States, although its active molecular formula, Eszopiclone, is sold under the name Lunesta. Zopiclone is a controlled substance in the United States, Japan, Brazil, and some European countries. Sepracor Pharmaceutical separated the active compound of Zopiclone and patented it as Lunesta.
Zopiclone has shown it may have a greater addictive potential than Benzodiazepines and has been described as a "benzodiazepine in disguise". Tolerance to the effects of Zopiclone can develop after a few weeks and abrupt withdrawal (particularly after prolonged use) can cause seizures and delirium.
Zopiclone was first developed by Sepracor and introduced in 1986 by Rhone-Poulenc S.A., now part of Sanofi-Aventis who is the main manufacturer. On April 4, 2005 the United States Drug Enforcement Agency listed Zopiclone under Schedule IV, due to the evidence that the drug has addictive properties similar to benzodiazepines.
Zopiclone is not recommended during pregnancy as it is secreted in human milk and its concentrations may reach 50% of the plasma levels. Zopiclone is not recommended to nursing mothers.
Zopiclone is cross-tolerant to Benzodiazepines and Alcohol, meaning that once tolerance to Zopiclone develops, the patient will also have tolerance to any Benzodiazepine and Alcohol. This places recovering alcoholics or benzodiazepine dependent individuals at a higher risk for dependency to Zopiclone.Zopiclone is not recommended during pregnancy as it is secreted in human milk and its concentrations may reach 50% of the plasma levels. Zopiclone is not recommended to nursing mothers.
*While great care has been taken in organizing and presenting the material throughout this website, please note that it is provided for informational purposes only and should not be taken as Medical Advice.
*The statements on this website have not been evaluated by the Food and Drug Administration (FDA). The products and labels mentioned / sold are not intended to diagnose, treat, cure, or prevent any disease or illness.
* Testimonial results may vary person to person.
*The program outlined in Point of Return is not meant to substitute your doctor, instead it is to be utilized with your physician to help you with your drug withdrawal process and with his or her consent.
*Because prescription medications can cause severe withdrawal reactions, do not stop taking any medication without first consulting your physician. The decision to taper any medication should be discussed with your doctor and done with their consent and support. More...